This workshop was held on February 20, 2012 in London. View the workshop programme.
Workshop report: Methods for adjusting for treatment switches in late-stage cancer trials
Click on the links below to view the slide presentations:
Methods for handling treatment switching: rank-preserving structural nested failure time models, inverse-probability-of-censoring weighting, and marginal structural models
Departure from treatment protocol in published RCTs: a review
Methods for adjusting survival estimates in the presence of treatment crossover - Simulation studies - Part A
Methods for adjusting survival estimates in the presence of treatment crossover - Simulation studies - Part B
Methods for health economic models in metastatic cancer
Adjusting the Crossover Effect in Survival Analysis Using a Rank Preserving Structural Failure Time Model: The Case of Sunitinib GIST Trial
Treatment switches in cancer trials - problems, pitfalls and (no) solutions
Dealing with treatment switches in cost-effectiveness analysis: the NICE experience- Part A
Dealing with treatment switches in cost-effectiveness analysis: the NICE experience- Part B